We found that NUDT21 could promote both in vivo and in vitro GBM cell proliferation, and our study implicates a critical role for NUDT21 in regulating the MES identity in GBM and suggests NUDT21 as an attractive therapeutic target for MES GBM treatment. This evidence concerns the gene NUDT21 and glioblastoma.